A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years
Clinical trial NCT05989672 · COMPLETED
Trial details
- NCT number
- NCT05989672
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-08
- Primary completion
- 2023-11-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.